» Articles » PMID: 38974966

MBNL2 Promotes Aging-related Cardiac Fibrosis Via Inhibited SUMOylation of Krüppel-like Factor4

Overview
Journal iScience
Publisher Cell Press
Date 2024 Jul 8
PMID 38974966
Authors
Affiliations
Soon will be listed here.
Abstract

Aging-related cardiac fibrosis represents the principal pathological progression in cardiovascular aging. The Muscleblind-like splicing regulator 2 (MBNL2) has been unequivocally established as being associated with cardiovascular diseases. Nevertheless, its role in aging-related cardiac fibrosis remains unexplored. This investigation revealed an elevation of MBNL2 levels in the aged heart and senescent cardiac fibroblasts. Notably, the inhibition of MBNL2 demonstrated a capacity to mitigate HO-induced myofibroblast transformation and aging-related cardiac fibrosis. Further mechanistic exploration unveiled that aging heightened the expression of SENP1 and impeded the SUMO1 binding with KLF4, and SUMOylation of KLF4 effectively increased by the inhibition of MBNL2. Additionally, the inhibition of TGF-β1/SMAD3 signaling attenuated the impact of over-expression of MBNL2 in inducing senescence and cardiac fibrosis. MBNL2, by orchestrating SUMOylation of KLF4, upregulating the TGF-β1/SMAD3 signaling pathway, emerges as a significant promoter of aging-related cardiac fibrosis. This discovery identifies a novel regulatory target for managing aging-related cardiac fibrosis.

Citing Articles

Functions of the Muscleblind-like protein family and their role in disease.

Zhou H, Xu J, Pan L Cell Commun Signal. 2025; 23(1):97.

PMID: 39966885 PMC: 11837677. DOI: 10.1186/s12964-025-02102-5.


Exploring the Impact of Microgravity on Gene Expression: Dysregulated Pathways and Candidate Repurposed Drugs.

Galcenko K, Bourdakou M, Spyrou G Int J Mol Sci. 2025; 26(3).

PMID: 39941055 PMC: 11818396. DOI: 10.3390/ijms26031287.


DsbA-L activates TGF-β1/SMAD3 signaling and M2 macrophage polarization by stimulating AKT1 and NLRP3 to promote pulmonary fibrosis.

Wang J, Xia Z, Qing B, Chen Y, Gu L, Chen H Mol Med. 2024; 30(1):228.

PMID: 39580448 PMC: 11585156. DOI: 10.1186/s10020-024-00983-9.


CheekAge, a next-generation epigenetic buccal clock, is predictive of mortality in human blood.

Shokhirev M, Kramer D, Corley J, Cox S, Cuellar T, Johnson A Front Aging. 2024; 5:1460360.

PMID: 39411517 PMC: 11473594. DOI: 10.3389/fragi.2024.1460360.

References
1.
Le N, Martin J, Fujiwara K, Abe J . Sub-cellular localization specific SUMOylation in the heart. Biochim Biophys Acta Mol Basis Dis. 2017; 1863(8):2041-2055. PMC: 5716640. DOI: 10.1016/j.bbadis.2017.01.018. View

2.
Triposkiadis F, Xanthopoulos A, Butler J . Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 74(6):804-813. DOI: 10.1016/j.jacc.2019.06.053. View

3.
Dimitrijevic Z, Salinger Martinovic S, Nikolic V, Cvetkovic T . Protein Carbonyl Content Is a Predictive Biomarker of Eccentric Left Ventricular Hypertrophy in Hemodialysis Patients. Diagnostics (Basel). 2019; 9(4). PMC: 6963343. DOI: 10.3390/diagnostics9040202. View

4.
Sheng Z, Zhu J, Deng Y, Gao S, Liang S . SUMOylation modification-mediated cell death. Open Biol. 2021; 11(7):210050. PMC: 8277462. DOI: 10.1098/rsob.210050. View

5.
Yu X, Lao Y, Teng X, Li S, Zhou Y, Wang F . SENP3 maintains the stability and function of regulatory T cells via BACH2 deSUMOylation. Nat Commun. 2018; 9(1):3157. PMC: 6082899. DOI: 10.1038/s41467-018-05676-6. View